Trusted | Longitudinal | Built for Evidence Generation

Alzheimer’s disease (AD) Real World Data

Delivering the clarity of real world insights, with sufficient scale, longitudinal depth and data quality to support confident decision-making.

Connect with our team

Accelerate Alzheimer's research and care with Real World Data (RWD)

Biopharma teams advancing Alzheimer’s programs face a shared reality; clinical trial data alone can no longer be enough to answer the questions that matter most.
As biomarker-driven testing expands in routine care, researchers need real world data that can help them:

Identify and characterize relevant patient populations at scale
See how biomarkers are ordered, sequenced and repeated in practice
Understand diagnostic pathways and disease progression
Generate evidence that informs development decisions and scientific communication

What makes Labcorp’s Alzheimer’s RWD distinct

Scale rooted in real world clinical practice

Labcorp brings unmatched scale to Alzheimer’s real-world evidence, with 285,000+ patients who have received Alzheimer’s biomarker testing in routine care—providing rare, population-level visibility in this disease area

Breadth across biomarker-driven evaluation

The dataset spans key Alzheimer’s biomarkers, including the ATN Profile, beta-amyloid 42/40 ratio, pTau-217, pTau-181, NfL, GFAP, pTau 217/beta amyloid ratio and APOE genotyping, capturing how testing is initiated, sequenced, and combined in real clinical workflows

Longitudinal insight into disease evaluation

Repeat testing and co-testing patterns enable longitudinal analysis of biomarker change over time—supporting insights into diagnostic refinement, disease monitoring and evolving clinical decision-making

Built on trust, quality and compliance

Derived from Labcorp’s clinical laboratory infrastructure, the datasets are HIPAA-compliant, quality-controlled and designed for regulatory-grade RWE, HEOR and scientific applications with confidence

AI-powered real-world data platform for Alzheimer's disease

Developed with Amazon Web Services (AWS) and Datavant, Labcorp’s AI-powered platform delivers longitudinal laboratory data at scale with advanced analytics to accelerate discovery, streamline drug development, and improve patient outcomes.

Learn More

Mother and daughter embracing themselves with smiles on their faces

Resources

Real world patterns of Alzheimer’s disease biomarker testing: insights from a large-scale clinical dataset

Let’s generate stronger evidence for Alzheimer’s - together

Your questions may lead to the next neurological breakthrough. Labcorp's Alzheimer's RWD can provide trusted clinical data that stands up to real-world complexity.

Connect with our RWD experts

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries